Attenuation of apomorphine-induced sensitization by buspirone

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 3, 2011, Pages 444-450

  Ikram, Huma ^a   Haleem, Darakhshan Jabeen ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

5 HT 1A receptors; Apomorphine; Behavioral sensitization; Buspirone; Serotonin

Indexed keywords

APOMORPHINE; BUSPIRONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; HYPERACTIVITY; LOCOMOTION; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOMORPHINE; BUSPIRONE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 79959845436     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.04.007     Document Type: Article

References (44)

1. Ago Y, Nakamura S, Baba A, Matsuda T. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice. J Pharmacol Sci 2008;106(1):15-21. (Pubitemid 351159064)
2. Ali I, Kelly ME. 8-OH-DPAT enhances the expression of cocaine-induced place preference. Br J Pharmacol Suppl 1996;119:207P.
3. Ali I, Kelly ME. Buspirone fails to affect cocaine-induced conditioned place preference in the mouse. Pharmacol Biochem Behav 1997;58:311-5. (Pubitemid 27394278)
4. Anagnostaras SG, Schallert T, Robinson TE. Memory processes governing amphetamine- induced psychomotor sensitization. Neuropsychopharmacology 2002;26:703-15. (Pubitemid 34455023)
5. Batool F, Siddiqui S, Haleem DJ. Neurochemical and behavioral profiles of 1-(1-naphthyl)piperazine in rats. J Coll Physicians Surg Pak 2000;11(1):50-6.
6. Bell K, Duffy P, Kalivas PW. Context-specific enhancement of glutamate transmission by cocaine. Neuropsychopharmacology 2000;23:335-44. (Pubitemid 30609667)
7. Bevan P. Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity. Neurosci Lett 1983;35(2):185-9. (Pubitemid 13120725)
8. Bloise E, Carey RJ, Carrera MP. Behavioral sensitization produced by a single administration of apomorphine: implications for the role of Pavlovian conditioning in the mediation of context-specific sensitization. Pharmacol Biochem Behav 2007;86:449-57. (Pubitemid 46466876)
9. Braga PQ, Dias FRC, Carey RJ, Carrera MP. Low dose apomorphine induces context-specific sensitization of hypolocomotion without conditioning: Support for a new state dependent retrieval hypothesis of drug conditioning and sensitization. Pharmacol Biochem Behav 2009a;93(2):128-33.
10. Braga PQ, Galvanho JP, Bloise E, Carey RJ, Carrera MP. The Expression of locomotor sensitization to apomorphine is dependent o time interval between injection and testing. Pharmacology, Biochemistry & Behav 2009b;91(3):278-82.
11. Burmeister JJ, Lungren EM, Kirschner KF, Neisewander JL. Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 2004;29:660-8. (Pubitemid 38402473)
12. Carey RJ, DePalma G, Damianopoulos EN, Hopkins A, Muller CP, Huston JP. Dopaminergic and serotonergic autoreceptor stimulation effects are equivalent and additive in the suppression of spontaneous and cocaine induced locomotor activity. Brain Res 2004;1019:134-43. (Pubitemid 39078619)
13. Crombag HS, Badiani A, Maren S, Robinson TE. The role of contextual versus discrete drug-associated cues in promoting the induction of psychomotor sensitization to intravenous amphetamine. Behav Brain Res 2000;116(1):1-22.
14. De La Garza R, Cunningham KA. The effects of the 5-hydroxytryptamine1A agonist 8- hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J Pharmacol Exp Ther 2000;292(2):610-7. (Pubitemid 30067424)
15. Deleu D, Hanssens Y, Northway MG. Subcutaneous apomorphine. An evidence-based review of its use in Parkinson's disease. Drugs Aging 2004;21:687-709.
16. Gobert A, Rivet JM, Cisterilli L, Melon C, Millan MJ. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions. Neuroscience 1999;93:1251-62. (Pubitemid 29397553)
17. Haleem DJ, Hasnat A, Shireen E, Khan A, Haleem MA. Dopamine and serotonin neurotransmission in the reinforcing effects of alcohol and apomorphine. J Coll Physicians Surg Pak 2005;15(8):458-62. (Pubitemid 41288606)
18. Haleem DJ, Khan NH. Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatr 2003;27(4):645-51.
19. Haleem DJ, Samad N, Haleem MA. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic receptors by buspirone in rats. Pharmacol Biol Behav 2007;87:115-21. (Pubitemid 46855825)
20. Haleem DJ, Shireen E, Haleem MA. Somatodendritic and postsynaptic 5-HT-1A receptors in the attenuation of haloperidol-induced catalepsy. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:1323-9. (Pubitemid 39592930)
21. Hall FS, Sora I, Drgonova J, Li XF, Goeb M, Uhl GR. Molecular mechanisms underlying the rewarding effects of cocaine. Ann NY Acad Sci 2004;1025:47-56. (Pubitemid 39643844)
22. Holroyd-Leduc JM, Liu BA, Maki BE, Zecevic A, Herrmann N, Black SE. The role of buspirone for the treatment of cerebellar ataxia in an older individual. Can J Clin Pharmacol 2005;12(3):e218-21.
23. Ikram H, Samad N, Haleem DJ. Neurochemical and behavioral effects of m-CPP in a rat model of tardive dyskinesia. Pak J Pharm Sci 2007;20(3):188-95.
24. Khan A, Haleem DJ. 5-HT-1A receptor responsiveness following subchronic administration of buspirone. Pak J Pharm Sci 2006;19(4):333-7.
25. Marin MT, Cruz FC, Planeta CS. Cocaine-induced behavioral sensitization in adolescent rats endures until adulthood: lack of association with GluR1 and NR1 glutamate receptor subunits and tyrosine hydroxylase. Pharmacol Biochem Behav 2008;91(1):109-14.
26. Muller CP, Carey RJ, Huston JP. Serotonin as an important mediator of cocaine's behavioral effects. Drugs Today 2003;39:497-511. (Pubitemid 37187415)
27. Muller CP, Carey RJ, Huston JP, De Souza Silva MA. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Prog Neurobiol 2007;81:133-78. (Pubitemid 46282275)
28. Naidu PS, Kulkarni SK. Effect of 5-HT-1A and 5-HT-2A/2 C receptor modulation on neuroleptic-induced vacuous chewing movements. Eur J Pharmacol 2001;428:81-6. (Pubitemid 32971760)
29. Neisewander JL, Pierce RC, Bardo MT. Naloxone enhances the expression of morphine-induced conditioned place preference. Psychopharmacology 1990;100:201-5. (Pubitemid 20038562)
30. Pahwa R, Koller WC, Trosch RM, Sherry JH. Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, doubleblind, placebo-controlled crossover evaluation of a single dose. J Neurol Sci 2007;258(1-2):137-43. (Pubitemid 46874490)
31. Peroutka SJ. Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors. Biol Psychiatry 1985;20:971-9. (Pubitemid 16042927)
32. Pierce RC, Kalivas PW. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Reviews 1997;25(2):192-216. (Pubitemid 27501800)
33. Przegaliski E, Siwanowicz J, Baran L, Filip M. Activation of serotonin (5-HT)1A receptors inhibits amphetamine sensitization in mice. Life Sci 2000;66(1):1011-9. (Pubitemid 30090391)
34. Riad M, Garcia S, Watkins KC, Jodoin N, Doucet E, Langlois X, El Mestikawy S, Hamon M, Descarries L. Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol 2000;417:181-94. (Pubitemid 30038263)
35. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 1993;18(3):247-91. (Pubitemid 23219500)
36. Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentivesensitization view. Addiction 2000;95(2):S91-S117. (Pubitemid 30650375)
37. Rosengarten H, Bartoszyk GD, Quartermain D, Lin Y. The effect of chronic administration of sarizotan, 5-HT-1A agonist/D3/D4 ligand on the previous termhaloperidolnext term-induced repetitive jaw movements in rat model of tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiat 2006;30:273-9. (Pubitemid 43288066)
38. Rowlett JK, Mattingly BA, Bardo MT. Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in rats. Neuropharmacology 1991;30(2): 191-7.
39. Sato H, Skelin I, Debonnel G, Diksic M. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites. Brain Res Bull 2008;75(5):545-55. (Pubitemid 351381815)
40. Schenk S. Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats. Pharmacol Biochem Behav 2000;67:363-9.
41. Shireen E, Haleem DJ. Motor effects of buspirone: relationship with dopamine and serotonin in the striatum. J Coll Physicians Surg Pak 2005;15(12):753-6.
42. Troisi JR, Critchfield TS, Griffiths RR. Buspirone and lorazepam abuse liability in humans: behavioral effects, subjective effects and choice. Behav Pharmacol 1993;4 (3):217-30. (Pubitemid 23181741)
43. Trulson ME, Trulson TJ. Buspirone decreases the activity of serotonin-containing neurons in the dorsal raphe in freely-moving cats. Neuropharmacology 1986;25 (11):1263-6. (Pubitemid 17185886)
44. Westbrook RF, Greeley JD. Conditioned tolerance to morphine hypoalgesia: compensatory hyperalgesia in the experimental group or conditioned hypoalgesia in the control group? Q J Exp Psychol 1992;45B:161-87.